Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes deliberately taking on more of its own economic exposure because it believes the outside world is mispricing what it already has. The key is: does management assert that the value assigned to the company or its assets is materially below what it's worth, grounded in something concrete, and is the company acting on it by acquiring, retaining, or concentrating that exposure? Looking at the transcript: Management discusses acquisitions, development, and equity issuance. They talk about buying properties at accretive yields, using equity as a cheaper capital source. They mention that they are issuing equity, not buying back shares. They are acquiring assets, but is that because they think those assets are mispriced? They say they are buying new, fully leased properties with below-market rents at accretive yields. They compare to development returns. They also mention that their cost of equity is lower than cost of debt, so they use equity to fund acquisitions. But is that a mispricing claim? They say "our cost of equity has been materially lower than our cost of short-term debt" - that's about capital costs, not about the value of their existing assets. They don't say their stock is undervalued; they are issuing equity, which typically implies they think the stock is fairly valued or overvalued. They are not buying back shares. They are acquiring more assets, but that's routine capital allocation, not necessarily because they think the assets are mispriced relative to intrinsic value. They do say they are buying properties at cap rates that are attractive relative to their cost of equity, but that's about new investments, not about their existing portfolio being undervalued. They also mention that they are seeing acquisition opportunities because of capital markets, but they don't claim that their existing assets are undervalued. They talk about their portfolio being strong, but no specific mispricing claim. They also mention that they are issuing equity, which is diluting existing owners, so that's the opposite of concentrating exposure. They are not retaining more exposure; they are raising capital. So the answer is NO. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.